All Emd Serono Research And Development Institute Inc Sponsors for H1B Applications - 2018

Explore H1B salary data for top companies like Emd-serono-research-and-development-institute-inc across different cities for various job titles and discover the average salaries.

Company name
Job Title
City Name
Average Salary
Emd Serono Research And Development Institute Inc Medicinal Chemist Burlington $ 70,000 / Year
Emd Serono Research And Development Institute Inc Research Associate Burlington $ 60,008 / Year
Emd Serono Research And Development Institute Inc Research Associate Immunology Burlington $ 68,000 / Year
Emd Serono Research And Development Institute Inc Associate Scientist Upstream Process Development Burlington $ 65,000 / Year
Emd Serono Research And Development Institute Inc Clinical Pharmacologist Burlington $ 125,000 / Year
Emd Serono Research And Development Institute Inc Associate Scientist Downstream Process Development Burlington $ 60,000 / Year
Emd Serono Research And Development Institute Inc Senior Principal Statistical Programmer Burlington $ 134,096 / Year
Emd Serono Research And Development Institute Inc Senior Statistician Burlington $ 105,000 / Year
Emd Serono Research And Development Institute Inc Associate Scientist I Burlington $ 83,126 / Year
Emd Serono Research And Development Institute Inc Associate Scientist Immuno Oncology Burlington $ 68,000 / Year
Emd Serono Research And Development Institute Inc Early Stage Global Project Manager Burlington $ 117,000 / Year
Emd Serono Research And Development Institute Inc Scientist I Clinical Bioanalytical Burlington $ 91,879 / Year

Last 5 Years H-1B Salary Data

h1bInfo.org is an independent website that displays public disclosure data in a user-friendly format. We have analyzed 10 years of H1B data from USCIS and the US Department of Labor, covering more than 6 million records from FY 2014 to FY 2023. However, for the latest and most accurate data, it's best to check the official sources directly. All content on H1BInfo is copyrighted and all rights are reserved from 2022 to 2023.